Ascentage Pharma Group Stock Price Prediction
| AAPG Stock | 27.88 1.39 5.25% |
Momentum 37
Sell Extended
Oversold | Overbought |
EPS Estimate Current Year (1.39) | EPS Estimate Next Year (0.48) | Wall Street Target Price 45.7143 | Quarterly Revenue Growth (0.72) |
Using Ascentage Pharma hype-based prediction, you can estimate the value of Ascentage Pharma Group from the perspective of Ascentage Pharma response to recently generated media hype and the effects of current headlines on its competitors.
Ascentage Pharma Hype to Price Pattern
Investor biases related to Ascentage Pharma's public news can be used to forecast risks associated with an investment in Ascentage. The trend in average sentiment can be used to explain how an investor holding Ascentage can time the market purely based on public headlines and social activities around Ascentage Pharma Group. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Ascentage Pharma's market sentiment to its price can help taders to make decisions based on the overall investors consensus about Ascentage Pharma.
The fear of missing out, i.e., FOMO, can cause potential investors in Ascentage Pharma to buy its stock at a price that has no basis in reality. In that case, they are not buying Ascentage because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Ascentage Pharma after-hype prediction price | USD 28.01 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Ascentage | Build AI portfolio with Ascentage Stock |
Ascentage Pharma After-Hype Price Prediction Density Analysis
As far as predicting the price of Ascentage Pharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Ascentage Pharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Ascentage Pharma, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Ascentage Pharma Estimiated After-Hype Price Volatility
In the context of predicting Ascentage Pharma's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Ascentage Pharma's historical news coverage. Ascentage Pharma's after-hype downside and upside margins for the prediction period are 24.55 and 31.47, respectively. We have considered Ascentage Pharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Ascentage Pharma is very steady at this time. Analysis and calculation of next after-hype price of Ascentage Pharma is based on 3 months time horizon.
Ascentage Pharma Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Ascentage Pharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Ascentage Pharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Ascentage Pharma, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.42 | 3.46 | 0.08 | 0.00 | 6 Events / Month | 0 Events / Month | In about 6 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
27.88 | 28.01 | 0.47 |
|
Ascentage Pharma Hype Timeline
Ascentage Pharma is presently traded for 27.88. The entity has historical hype elasticity of -0.08, and average elasticity to hype of competition of 0.0. Ascentage is projected to increase in value after the next headline, with the price projected to jump to 28.01 or above. The average volatility of media hype impact on the company the price is over 100%. The price rise on the next news is projected to be 0.47%, whereas the daily expected return is presently at -0.42%. The volatility of related hype on Ascentage Pharma is about 0.0%, with the expected price after the next announcement by competition of 27.88. The company reported the previous year's revenue of 980.65 M. Net Loss for the year was (395.25 M) with profit before overhead, payroll, taxes, and interest of 354.93 M. Given the investment horizon of 90 days the next projected press release will be in about 6 days. Check out Ascentage Pharma Basic Forecasting Models to cross-verify your projections.Ascentage Pharma Related Hype Analysis
Having access to credible news sources related to Ascentage Pharma's direct competition is more important than ever and may enhance your ability to predict Ascentage Pharma's future price movements. Getting to know how Ascentage Pharma's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Ascentage Pharma may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| CTXR | Citius Pharmaceuticals | 0.00 | 0 per month | 5.57 | 0 | 13.83 | (9.49) | 36.73 | |
| DARE | Dare Bioscience | 0.00 | 0 per month | 3.71 | 0.02 | 6.55 | (5.73) | 26.52 | |
| LGVN | Longeveron LLC | 0.00 | 0 per month | 0.00 | (0.13) | 8.24 | (6.02) | 24.65 | |
| FBLG | FibroBiologics, Common Stock | 0.00 | 0 per month | 0.00 | (0.12) | 11.43 | (10.91) | 47.13 | |
| ATHA | Athira Pharma | 0.00 | 0 per month | 3.00 | 0.15 | 9.33 | (4.62) | 58.60 | |
| PULM | Pulmatrix | 0.00 | 0 per month | 0.00 | (0.14) | 6.58 | (8.10) | 51.95 | |
| ASBP | Aspire BioPharma, | 0.00 | 7 per month | 0.00 | (0.08) | 17.23 | (20.00) | 137.50 | |
| ADTX | Aditxt Inc | 0.00 | 0 per month | 0.00 | (0.41) | 19.39 | (28.09) | 63.67 | |
| MBRX | Moleculin Biotech | 0.00 | 0 per month | 0.00 | (0.19) | 9.76 | (11.73) | 41.63 |
Ascentage Pharma Additional Predictive Modules
Most predictive techniques to examine Ascentage price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Ascentage using various technical indicators. When you analyze Ascentage charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Ascentage Pharma Predictive Indicators
The successful prediction of Ascentage Pharma stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Ascentage Pharma Group, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Ascentage Pharma based on analysis of Ascentage Pharma hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Ascentage Pharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Ascentage Pharma's related companies. | 2022 | 2023 | 2024 | 2025 (projected) | Payables Turnover | 0.23 | 0.42 | 0.32 | 0.46 | Days Of Inventory On Hand | 156.77 | 193.2 | 82.79 | 78.65 |
Story Coverage note for Ascentage Pharma
The number of cover stories for Ascentage Pharma depends on current market conditions and Ascentage Pharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Ascentage Pharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Ascentage Pharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Ascentage Pharma Short Properties
Ascentage Pharma's future price predictability will typically decrease when Ascentage Pharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Ascentage Pharma Group often depends not only on the future outlook of the potential Ascentage Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Ascentage Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 302.1 M | |
| Cash And Short Term Investments | 1.2 B |
Complementary Tools for Ascentage Stock analysis
When running Ascentage Pharma's price analysis, check to measure Ascentage Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ascentage Pharma is operating at the current time. Most of Ascentage Pharma's value examination focuses on studying past and present price action to predict the probability of Ascentage Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ascentage Pharma's price. Additionally, you may evaluate how the addition of Ascentage Pharma to your portfolios can decrease your overall portfolio volatility.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |